Anti-LILRB1 antibody [GHI/75]
Be the first to review this product! Submit a review
|
(1 Publication)
Mouse Monoclonal LILRB1 antibody. Suitable for Flow Cyt and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Cell preparation containing LILRB1 protein.
View Alternative Names
CD85j, ILT2, LIR1, MIR7, LILRB1, Leukocyte immunoglobulin-like receptor subfamily B member 1, LIR-1, Leukocyte immunoglobulin-like receptor 1, CD85 antigen-like family member J, Immunoglobulin-like transcript 2, Monocyte/macrophage immunoglobulin-like receptor 7, ILT-2, MIR-7
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-LILRB1 antibody [GHI/75] (AB185325)
Flow cytometry analysis of human peripheral blood labeling CD85j/LILRB1 using ab185325 at 1 µg/mL. CD19 is labeled using an Anti_human CD19-PE conjugate at 20 µL/100ul blood. Secondary antibody is a Goat Anti-Mouse APB conjugate. Surface staining.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-LILRB1 antibody [GHI/75] (AB185325)
Flow cytometry analysis of human peripheral blood labeling CD85j/LILRB1 using ab185325 at 1 µg/mL. Secondary antibody is a Goat Anti-Mouse APB conjugate. Surface staining.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-LILRB1 antibody [GHI/75] (AB185325)
Flow cytometry analysis of human peripheral blood labeling CD85j/LILRB1 using ab185325 at 1 µg/mL. CD85j/LILRB1-positive B-cells (Red) are separated from CD85j/LILRB1-negative neutrophil granulocytes (Black, dashed line). Secondary antibody is a Goat Anti-Mouse APB conjugate. Surface staining.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LILRB1 functions as an inhibitory receptor that dampens immune system activation by recruiting SHP-1 and SHP-2 phosphatases. As part of a complex with other immune checkpoint molecules LILRB1 modulates the balance between activating and inhibitory signals in immune cells. Its inhibitory signaling prevents excessive inflammation by reducing cytokine production and limiting T cell proliferation.
Pathways
This protein plays a role in immune signaling pathways specifically through interactions with proteins involved in the regulation of immune responses such as KIRs (Killer-cell Immunoglobulin-like Receptors). It participates in pathways that control the inhibitory signals controlling immune activity like the NK cell cytotoxicity pathway and the Fc gamma R-mediated phagocytosis pathway. Through these mechanisms LILRB1 maintains immune equilibrium and preserves tissue integrity during immune responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
The Journal of clinical investigation 134: PubMed38625739
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com